Integral Ad Science (NASDAQ:IAS) Price Target Cut to $12.50 by Analysts at Morgan Stanley

Integral Ad Science (NASDAQ:IAS - Free Report) had its target price decreased by Morgan Stanley from $13.50 to $12.50 in a research report report published on Thursday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock.

IAS has been the subject of several other research reports. Truist Financial raised their price objective on shares of Integral Ad Science from $16.00 to $17.00 and gave the stock a "buy" rating in a research note on Monday, March 3rd. Oppenheimer reiterated an "outperform" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Robert W. Baird reaffirmed a "neutral" rating and issued a $9.00 price target (down previously from $16.00) on shares of Integral Ad Science in a research note on Friday, March 28th. Scotiabank began coverage on shares of Integral Ad Science in a research note on Friday, February 28th. They issued a "sector perform" rating and a $12.00 target price on the stock. Finally, Benchmark reiterated a "hold" rating on shares of Integral Ad Science in a report on Friday, February 28th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $14.35.

Integral Ad Science Price Performance

Shares of NASDAQ:IAS traded up $0.11 on Thursday, reaching $6.52. The company's stock had a trading volume of 1,064,614 shares, compared to its average volume of 1,110,668. The company has a 50-day simple moving average of $8.85 and a 200 day simple moving average of $10.09. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71. The company has a market cap of $1.07 billion, a P/E ratio of 32.60, a PEG ratio of 1.06 and a beta of 1.53. Integral Ad Science has a 52-week low of $6.32 and a 52-week high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). The company had revenue of $153.00 million for the quarter, compared to analysts' expectations of $148.83 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company's revenue for the quarter was up 13.9% on a year-over-year basis. During the same quarter last year, the company earned $0.06 earnings per share. As a group, equities research analysts anticipate that Integral Ad Science will post 0.26 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Lisa Utzschneider sold 68,671 shares of the stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $7.44, for a total value of $510,912.24. Following the completion of the transaction, the chief executive officer now directly owns 334,051 shares of the company's stock, valued at $2,485,339.44. This trade represents a 17.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold a total of 90,303 shares of company stock worth $706,660 in the last 90 days. 2.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Integral Ad Science

A number of large investors have recently made changes to their positions in the stock. Barclays PLC grew its stake in Integral Ad Science by 207.1% during the 3rd quarter. Barclays PLC now owns 127,733 shares of the company's stock valued at $1,380,000 after purchasing an additional 86,133 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Integral Ad Science by 47.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock valued at $7,756,000 after acquiring an additional 231,271 shares during the period. Franklin Resources Inc. boosted its holdings in shares of Integral Ad Science by 12.9% in the 3rd quarter. Franklin Resources Inc. now owns 110,449 shares of the company's stock valued at $1,191,000 after acquiring an additional 12,647 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Integral Ad Science by 1.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 603,848 shares of the company's stock worth $6,304,000 after acquiring an additional 7,941 shares during the period. Finally, Handelsbanken Fonder AB purchased a new position in shares of Integral Ad Science during the fourth quarter worth $162,000. 95.78% of the stock is owned by hedge funds and other institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.